Schedule 13G ownership disclosure
GoodRx Holdings Inc
Common Stock · CUSIP: 38246G108
Event date: 2025-09-30
- Filing-level shares
- 9,207,340
- Percent of class
- 9.33%
- The Vanguard Group
Shares: 9,207,340 · Class: 9.33%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000102909-25-000171
- Form type
- SCHEDULE 13G/A
- Filer
- GoodRx Holdings, Inc.
- CIK
- CIK 1809519
- Filed
- Oct 30, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership